Enterprise Innovation

Weill Cornell Medicine Enterprise Innovation engages and collaborates with Weill Cornell Medicine faculty and trainees while fostering alliances with leaders in the biomedical industry and business and investment community. Our focus is to translate the application of emerging science and new technologies into world-class medical breakthroughs.

Integrating Weill Cornell Medicine’s different teams and resources under a single, united organization, Enterprise Innovation encompasses the entire spectrum of an effective innovation ecosystem. We offer unique opportunities for faculty and trainees to transform their research into medical advances through collaborations including access to the Sanders Tri-Institutional Therapeutics Discovery Institute.

News

BioInnovate Conference Showcases Path from Innovation to Scale Through a Growing Ecosystem

May 7, 2026

Over 200 scientists, startup founders and partners in government and industry gathered at Uris Auditorium on April 23 for the 2026 BioInnovate Conference. 
Improving Lives Through Academic Innovation, Commercialization and Entrepreneurship

December 5, 2025

Weill Cornell Medicine’s Ninth Annual Dean’s Symposium on Innovation and Entrepreneurship celebrated and fostered the entrepreneurial spirit on Nov. 17 at Weill Cornell's Griffis...
Study Pinpoints Source of Free Radicals in the Brain that May Fuel Dementia

November 4, 2025

Researchers have discovered that free radicals generated at a specific site in non-neuronal brain cells called astrocytes, may promote dementia, according to a Weill Cornell...